On that same note, I find that a bit surprising too, because people who have manufacturing facilities can't get the materials for them. Even if you get the patent or the formula to make it, if you can't get the raw materials, it doesn't solve the problem. When a pandemic happens, the whole world is seeking the same ingredients and, therefore, even if they have manufacturing facilities, I don't see how they could solve that problem.
You will always have concentration of manufacturing in places that can specialize in it and make millions daily, if not hundreds of millions monthly. The problem is a lot more complex than giving a waiver of some sort, because when you come to things like this, you also have to have the ingredients and the manufacturing ability to make it and the wherewithal and the will of the country to deliver those.
We're noticing that more of a problem is not so much the vaccines' availability as delivering them into the arms that need them. How we improve that is the real issue, rather than giving rights to manufacture them without giving the necessary ingredients and the ability to put them in people's arms.